Dr. Jason Fish
Department of Laboratory Medicine & Pathobiology
Cross-appointed: Institute of Medical Science
Awards: Canada Research Chair in Vascular Cell and Molecular Biology
Research Synopsis: The Fish lab investigates the molecular mechanisms that control endothelial cell biology. For example, we are seeking to decipher the signaling pathways and downstream transcriptional mediators that control responses to differentiation signals (e.g. artery/vein specification and angiogenesis) as well as pro-inflammatory factors.
We have identified important roles for noncoding RNAs such as microRNAs in modulating signaling pathways in endothelial cells. For example, we identified a microRNA, miR-146a, which is induced by inflammatory signaling pathways and acts as a negative feedback regulator to quench endothelial cell activation.
We have recently discovered that endothelial cells can package anti-inflammatory microRNAs into secreted extracellular vesicles and that these vesicles can suppress monocyte activation through microRNA transfer.
Studies from our lab and others are revealing an elaborate cell-cell communication network among cells in the cardiovascular system that is mediated in part by microRNA transfer. This is an exciting area of cardiovascular biology that is likely important for homeostasis and disease. Our current work is seeking to determine the role of long non-coding RNAs and microRNAs (particularly circulating microRNAs) in cardiovascular disease pathology.
We utilize a multi-disciplinary approach for our studies of endothelial cells, which includes zebrafish developmental biology models, mouse models of vascular disease, cultured human endothelial cells and assessment of human clinical samples.
Our experimental approaches include the analysis and functional interrogation of cell signaling and gene expression pathways, genome-wide approaches to uncover transcriptional networks, genome engineering using CRISPR technology, and investigation of extracellular vesicle biology.
Contact: jason.fish@utoronto.ca
Dr. Kathryn Howe
Institute of Medical Science
Cross-appointed: Department of Laboratory Medicine & Pathobiology
Awards: Wiley Scholar 2020
Research Synopsis: Kathryn is a Vascular Surgeon-Scientist at the University Health Network and Toronto General Hospital Research Institute. She is an Associate Professor in the Department of Surgery. The central clinical and scientific focus is to understand the role of endothelial communication within vulnerable carotid atherosclerotic plaques to find new targets to prevent stroke. Within this framework, the Howe lab investigates the molecular mechanisms that underlie endothelial cell function in health and disease. Projects include endothelial communication in atherosclerosis, endothelial identity in vascular diseases, endothelial dysfunction in COVID-19, vascular aging and endothelial senescence. Studies from our lab are revealing an elaborate and directional cell-cell communication network among cells in the cardiovascular system that is mediated in part by extracellular vesicles (EVs), microRNA, proteins, and cellular signaling and transcriptional pathways. Our current work is determining the role of endothelial cell function and communication in cardiovascular health and disease (e.g., atherosclerosis, aneurysm, aging and stroke) using a multidisciplinary approach that includes cultured vascular cells, mouse models, and human samples from the Peter Munk Cardiac Centre Biobank. We seek to identify vascular disease mechanisms and endothelial biomarkers for early disease detection and are leveraging the information gleaned from endothelial-focused models to develop novel therapies to combat cardiovascular disease.
Contact: kathryn.howe@uhn.ca